克罗恩病多学科团队:应该介绍谁?
Meagan Derbyshire1, Yaniv Zager1, Katherine Carson2
1Department of Colon & Rectum Surgery, AdventHealth, Orlando, FL, USA; Surgical Health Outcomes Consortium (SHOC), Advent Health Digestive Institute, Orlando, FL, USA.
概括
对于克罗恩氏病 (CD) 患者的多学科团队 (MDT) 会议往往呈现较年轻的个体,BMI较低,往往导致手术干预. 需要进一步的研究来确定这些关键讨论的最佳患者选择.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 炎症性肠道疾病研究研究
背景情况:
- 多学科团队 (MDT) 会议是管理良性和恶性结直肠疾病的标准.
- 支持MDT在炎症性肠病 (IBD),特别是克罗恩病 (CD) 的益处和患者选择的证据有限.
- 在IBD管理方面的进步需要明确的临床决策策略.
研究的目的:
- 确定目前在CDMDT会议上提出的患者人口统计和特征.
- 评估在CD患者管理中遵守MDT建议.
- 为了比较在MDT中讨论的CD患者与非CD患者之间的结果.
主要方法:
- 一个回顾性观察性研究是在一个医院系统内进行的,持续了十二个月.
- 数据从前性MDT数据库和回顾性图表审查中收集.
- 统计分析,包括千平方和学生t测试,比较了在MDT呈现的患者与那些没有.
主要成果:
- 在766名CD患者中,有52名在MDT会议上进行了审查.
- 与非MDT患者 (p <0.05) 相比,在MDT接受治疗的患者年龄更小 (43.4岁与44.9岁),体质量指数较低 (23.6岁与26.1岁).
- 在MDT组中,手术干预的频率明显高 (46.2%对23.2%,p <0.05).
结论:
- MDT会议可以指导IBD和CD的治疗决策.
- 目前的趋势表明,更年轻,BMI较低的CD患者更愿意接受手术考虑.
- 需要进一步的前性研究来确定MDT在CD管理中的表现的最终标准.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
Inflammatory Bowel Disease II: Crohn's Disease
134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134


